Form 4 holding
Chief Financial Officer
9 METERS BIOPHARMA, INC.
- Security class
- Common stock
- Shares / value
- 194,338
- Estimated value
- $44,251
- Report date
- 14 Sep 2021
- Price
- $0.2277
- Ownership
- Direct
Edward J. Sitar
Insider Reports History
- Reporting-owner location
- Mahwah, NJ
- Latest reporting-owner signature
-
/s/ Joseph Lucchese, Power of Attorney
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Edward J. Sitar
Form 4 holding
Director
Timber Pharmaceuticals, Inc.
- Security class
- Common Stock, par value $0.001 per share
- Shares / value
- 11,127
- Estimated value
- $18,126
- Report date
- 15 Apr 2023
- Price
- $1.63
- Ownership
- Direct
Form 4 holding
Director
Timber Pharmaceuticals, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 5,327
- Estimated value
- Report date
- 15 Apr 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Edward J. Sitar
4
Timber Pharmaceuticals, Inc.
- Report period
- 15 Apr 2023
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 18 Apr 2023, 11:33
- Role
- Director
- Next action
- Open filing details
4
Timber Pharmaceuticals, Inc.
- Report period
- 15 Dec 2022
- Transactions
- 1
- Transaction value
- +$4,072
- Accepted by SEC
- 16 Dec 2022, 15:05
- Role
- Director
- Next action
- Open filing details
4
Timber Pharmaceuticals, Inc.
- Report period
- 15 Apr 2022
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 19 Apr 2022, 12:58
- Role
- Director
- Next action
- Open filing details
4
Timber Pharmaceuticals, Inc.
- Report period
- 23 Nov 2021
- Transactions
- 1
- Transaction value
- +$6,900
- Accepted by SEC
- 24 Nov 2021, 15:07
- Role
- Director
- Next action
- Open filing details
4
9 METERS BIOPHARMA, INC.
- Report period
- 14 Sep 2021
- Transactions
- 1
- Transaction value
- +$18,300
- Accepted by SEC
- 15 Sep 2021, 08:12
- Role
- Chief Financial Officer
- Next action
- Open filing details
4
Timber Pharmaceuticals, Inc.
- Report period
- 01 Jul 2021
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 06 Jul 2021, 16:07
- Role
- Director
- Next action
- Open filing details